Welcome to LookChem.com Sign In|Join Free

CAS

  • or

147291-66-5

147291-66-5

Post Buying Request

147291-66-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

147291-66-5 Usage

Description

Tert-Butyl 3-aminobenzylcarbamate is a carbamate derivative used as a building block in the pharmaceutical industry for the synthesis of various drugs and organic compounds. Its unique chemical structure, featuring a tert-butyl group that provides stability and protection to the amine and carbamate functional groups, makes it a valuable tool in medicinal chemistry research and the production of diverse pharmaceutical compounds.

Uses

Used in Pharmaceutical Industry:
Tert-Butyl 3-aminobenzylcarbamate is used as a building block for the synthesis of novel drug candidates, contributing to the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Medicinal Chemistry Research:
tert-Butyl 3-aminobenzylcarbamate is utilized in medicinal chemistry research to explore its unique chemical structure and reactivity, which can lead to the discovery of innovative drug candidates and enhance the understanding of chemical reactions in drug synthesis processes.

Check Digit Verification of cas no

The CAS Registry Mumber 147291-66-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,2,9 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 147291-66:
(8*1)+(7*4)+(6*7)+(5*2)+(4*9)+(3*1)+(2*6)+(1*6)=145
145 % 10 = 5
So 147291-66-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H18N2O2/c1-12(2,3)16-11(15)14-8-9-5-4-6-10(13)7-9/h4-7H,8,13H2,1-3H3,(H,14,15)

147291-66-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl 3-aminobenzylcarbamate

1.2 Other means of identification

Product number -
Other names tert-butyl N-[(3-aminophenyl)methyl]carbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:147291-66-5 SDS

147291-66-5Relevant articles and documents

Cannabinoid receptor light-operated ligand and preparation method and application thereof

-

Paragraph 0066; 0073-0078, (2021/01/24)

The invention relates to the technical field of biology, in particular to a novel cannabinoid receptor light-operated ligand and a preparation method and application thereof. Disclosed is the cannabinoid receptor light-operated ligand or the isomer prodrug, the solvate and the pharmaceutically acceptable salt of the cannabinoid receptor light-operated ligand, wherein the structural formula of thecannabinoid receptor light-operated ligand is A-linker-B; A is a transmembrane domain ligand structure, and B is a light-operated element; Linker is a subunit which is linear and has no activity on acannabinoid receptor light-operated ligand. According to the invention, the cannabinoid receptor ligand is integrated with azobenzene through a proper connector, so that the ligand configuration is changed under an illumination condition, and the activation or inhibition state of the cannabinoid receptor is regulated and controlled.

PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS

-

Paragraph 00175, (2021/08/13)

N-(3-Substituted thiazol-2(3H)-ylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides and N-(3-substituted oxazol-2(3H)-ylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides (I) and (II) are disclosed. The compounds activate Yap and inhibit Lats kinases. They are therefore useful for treating hearing loss.

Identification of SENP1 inhibitors through in silico screening and rational drug design

Zhao, Yaxue,Wang, Zhongli,Zhang, Jianchen,Zhou, Huchen

, p. 178 - 184 (2016/07/06)

The small ubiquitin-related modifier (SUMO)-specific proteases (SENPs) catalyze the deconjugation of SUMO from their substrate proteins. SENP1 which is the most studied isoform is closely related to many cancers such as prostate cancer and colon cancer, t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 147291-66-5